Recent Articles

• 
  Biotech

  From Livestock to Microbes: Roadmap for Next-Gen Protein

  KAIST joint research team that has presented the conditions for successful industrialization of “microbial foods,” a next-generation protein source. From left: Distinguished Professor Sang Yup Lee of the Department of Chemical and Biomolecular Engineering at KAIST, PhD candidate Seok Young Jeong, an

  2026.08.31
• 
  Public Health

  Seoul to Cover 80% of Home Care Fees

  From next month, older adults living in Seoul who have mobility difficulties and receive home visit medical care from a doctor will be able to have 80% of their copayment covered by the Seoul Metropolitan Government. On the 30th, the Seoul Metropolitan Government announced that it will implement thi

  2026.08.31
• 
  Medical / Research

  Scientists identify key switch that slows Alzheimer’s

  Jeong Won-seok, deputy director of the Center for Vascular Research at the Institute for Basic Science (IBS), gives a briefing on the identification of a key regulatory factor that worsens Alzheimer’s disease at the Sejong Government Complex in Sejong on the morning of the 26th. 2026.08.27. Sejong=N

  2026.08.27
• 
  Medical / Drug Development

  Exclusive: New Dosing Method Blocks Genetic Side Effects of Dementia Drug

  ⓒNewsis A Korean research team has developed, for the first time in the world, a dosing method for “Leqembi,” a dementia treatment that removes the brain protein responsible for Alzheimer’s disease, which dramatically reduces its side effects. Leqembi is a new drug used for patients with mild cognit

  2026.08.27
• 
  Global Business

  SK Biopharm Invests KRW 1.1 Trillion, Secures Epilepsy Drug Exclusivity

  Lee Dong-hoon, President and CEO of SK Biopharmaceuticals, speaks about the introduction of a late-stage clinical epilepsy drug candidate at an emergency press conference held by SK Biopharmaceuticals at The Westin Josun Seoul in Sogong-dong, Seoul, on the 26th. 2026.8.26/News1 SK Biopharmaceuticals

  2026.08.27
• 
  AI Healthcare

  AI Flags Aspiration Risk in Two Seconds

  Professor Ryu Joo-seok, Senior Researcher Kim Jeong-min. A study has found that the risk of aspiration can be screened using just a 2-second “ah~” sound made immediately after swallowing food. The technology is expected to have potential as a simple method to check for swallowing disorders, which ar

  2026.08.26
• 
  Pharmaceutical R&D

  New Radiotherapy Targets Cancer Cells and Their ‘Nests’

  From left: Professor Myung Seung-jae, Department of Gastroenterology; Professor Oh Seung-joon, Department of Nuclear Medicine; Professor Yoo Chang-hoon, Department of Oncology; Professor Jung Byung-kwan, Department of Pathology; and Professor Son Byung-ho, Department of Breast Surgery, Asan Medical

  2026.08.26
• 
  Biopharma

  Hanmi Exports Record KRW 3.2 Trillion Obesity Drug Tech to Genentech

  Hanmi Pharmaceutical. Newsis Hanmi Pharmaceutical has licensed out a next-generation obesity drug candidate, designed to reduce weight while increasing muscle mass, to Genentech, a subsidiary of global pharmaceutical group Roche, in a deal worth up to USD 2.3 billion (approximately KRW 3.2 trillion)

  2026.08.25
• 
  Celltrion

  Celltrion Seeks Approval for Keytruda Biosimilar

  Panoramic view of a Celltrion plant. Provided by Celltrion. Celltrion has applied for domestic marketing approval for a biosimilar of MSD’s blockbuster immuno-oncology drug Keytruda, targeting a market worth KRW 44 trillion per year. The company plans to expand its oncology portfolio by adding an im

  2026.08.24
• 
  Public Health

  Government Moves to Fully Expand Drug Delivery

  A pharmacy in Seoul on the 4th. 2026.08.04. [Seoul=Newsis] The government is pushing to improve the system so that all patients who receive telemedicine consultations can receive medication delivery. On the 20th, the Ministry of Health and Welfare, the Ministry of SMEs and Startups, and the Office f

  2026.08.21